7125 Tolerability and adverse events of sunitinib in Japanese patients with advanced renal cell carcinoma

MLA

Hirotugu Uemura, et al. “7125 Tolerability and Adverse Events of Sunitinib in Japanese Patients with Advanced Renal Cell Carcinoma.” European Journal of Cancer Supplements, vol. 7, Sept. 2009, pp. 430–31. EBSCOhost, https://doi.org/10.1016/s1359-6349(09)71458-2.

APA

Hirotugu Uemura, T. Oki, S. Nagae, Y. Mochida, K. Nishigaki, Masahiro Nozawa, T. Minami, Y. Okuda, & Taiji Hayashi. (2009). 7125 Tolerability and adverse events of sunitinib in Japanese patients with advanced renal cell carcinoma. European Journal of Cancer Supplements, 7, 430–431. https://doi.org/10.1016/s1359-6349(09)71458-2

Chicago

Hirotugu Uemura, T. Oki, S. Nagae, Y. Mochida, K. Nishigaki, Masahiro Nozawa, T. Minami, Y. Okuda, and Taiji Hayashi. 2009. “7125 Tolerability and Adverse Events of Sunitinib in Japanese Patients with Advanced Renal Cell Carcinoma.” European Journal of Cancer Supplements 7 (September): 430–31. doi:10.1016/s1359-6349(09)71458-2.